Reporter Jan 20 2017
Jan. 19, 2017—Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.
Jan. 19, 2017—The Vanderbilt Digestive Disease Research Center (VDDRC) celebrates its 15th anniversary this year with a third consecutive five-year renewal of its federal research grant.
Jan. 19, 2017—David Gordon, M.D., dean of the University of Akron College of Health Professions, gave the 2017 Martin Luther King Jr. Commemorative Lecture on Monday at Vanderbilt, touching on the theme of teamwork as it relates to health care diversity.
Jan. 19, 2017—Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings.
Jan. 19, 2017—More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents.
Jan. 19, 2017—“EpicLeap by the Numbers” is a recently created infographic that gathers, in one place, an array of data points that demonstrate the remarkable magnitude of the EpicLeap program.
Jan. 19, 2017—Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.
Jan. 19, 2017—Annie Marie Garraway, Ph.D., has created the Levi Watkins Jr., M.D. Scholarship in honor of her late brother, Levi Watkins Jr., M.D.